Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Editor-in-Chief

New Content ItemGerry Melino, Cambridge University, England

Gerry Melino is Head of the Apoptosis & Cancer Laboratory, Medical Research Council Toxicology Unit, UK; and Professor of Molecular Biology (Medicine), University of Rome "Tor Vergata". He was awarded the Academia Lincei "Feltrinelli" Prize, the highest distinction by the President of Italy. His scientific interest focuses upon programmed cell death in cancer and skin. On the epidermis he works on the molecular events leading to death of keratinocytes, both in animal models as well as in human pathologies. Gerry's major work investigates the two recently identified members of the p53 family – p63 and p73. The molecular events driven by DNA damage to elicit the function of p63/p73 is investigated in vitro (transcriptional targets, proteosomal degradation, inhibitors) as well in ad hoc transgenic animal models.

Journal Sections

Biology Direct publishes in the following sections:

Articles

Annual Journal Metrics

\